News

Frontier IP Group plc is an LSE AIM listed Company that builds value by uniting science, industry and finance to commercialise university intellectual property.

Their strategy is based on proving the commercial worth of IP developed by their portfolio companies before raising significant sums of money to support their further growth. They earn equity stakes in return for providing a range of hands-on commercialisation services.

The spin outs they work with include those at the cutting edge of developing new vaccines and antibiotics, agricultural robotics, sustainable materials and improving the energy efficiency of solar cells and power converters.

Their portfolio companies’ IP is based on research from universities in the UK and Portugal, including Cambridge, Plymouth, Heriot-Watt, the University of Central Lancashire, NOVA University, Lisbon FCT NOVA, and INESC TEC.

Firm placing, conditional placing, subscription and retail offer

On 17 June 2026, the Company announced that the placing and the subscription had conditionally raised gross proceeds of approximately £4.0 million. Then on 19 June 2026, the Company further announced that the retail offer had conditionally raised in aggregate an additional £0.4 million.

Having helped Frontier IP with the production of their admission document when they floated on AIM back in January 2011 and subsequently helped with the design and production of their annual report for many years, the Perivan shareholder communications team was delighted to work with Allenby Capital who acted as Nominated Adviser and Broker and Addleshaw Goddard who acted as legal adviser on the production of the documentation which was posted to qualifying shareholders on 22 June 2026.

Perivan specialise in producing and publishing financial documents relating to shareholder and investor communications for quoted companies and are a market leader for the production of documentation relating to corporate finance transactions.